Management and Treatment of Placenta Previa
Placenta previa requires careful management with hospitalization for symptomatic patients, activity modification, avoidance of digital vaginal examinations, and planned cesarean delivery at 35-36 weeks to reduce maternal and fetal morbidity and mortality. 1, 2
Diagnosis and Classification
- Placenta previa is diagnosed when the placenta overlies the internal cervical os, occurring in approximately 0.4% of pregnancies in the third trimester 1
- Transvaginal ultrasound is the diagnostic modality of choice for accurate assessment of placenta previa 1, 3
- Digital pelvic examination should be avoided until placenta previa has been excluded to prevent triggering hemorrhage 1
- Placenta previa is common in early pregnancy (42.3% at 11-14 weeks, 3.9% at 20-24 weeks) but most resolve by 28 weeks 1
Risk Assessment
- Risk factors include prior cesarean delivery, pregnancy termination, intrauterine surgery, smoking, multifetal gestation, increasing parity, and advanced maternal age 3, 2
- Women with placenta previa and prior cesarean deliveries should be evaluated for placenta accreta spectrum disorder, which significantly increases morbidity 1, 3
- Women with one episode of bleeding may be at increased risk for subsequent bleeding episodes 1
Management Approach
Antepartum Management
- Women with asymptomatic placenta previa before 28 weeks can continue moderate-to-vigorous physical activity (MVPA) 1
- After 28 weeks, women with placenta previa should avoid moderate-to-vigorous physical activity but can maintain activities of daily living and low-intensity activity such as walking 1
- Hospitalization is recommended for women with:
- For women without these complications, decisions about hospitalization should be individualized based on risk factors and patient preference 1
- Optimize hemoglobin values during pregnancy; treat anemia with oral or intravenous iron as needed 1
Delivery Planning
- Delivery should take place at an institution with adequate blood banking facilities and multidisciplinary expertise 1, 3
- Planned cesarean delivery is recommended for complete placenta previa at 35-36 weeks after administration of antenatal corticosteroids 3, 4
- Preoperative coordination with anesthesiology, maternal-fetal medicine, neonatology, and expert pelvic surgeons is essential 1
- Notify blood bank in advance due to frequent need for large-volume blood transfusion 1
Intraoperative Management
- The most accepted approach is cesarean delivery with careful surgical planning 1
- Considerations for cesarean delivery include:
- Dorsal lithotomy positioning to allow access to vagina and optimal surgical visualization 1
- Vertical or wide transverse skin incisions may be used based on operator judgment 1
- Inspect the uterus after peritoneal entry to determine placental location and optimize uterine incision approach 1
- When possible, make the uterine incision away from the placenta 1
- After delivery of the fetus, leave the placenta in situ if there is evidence of abnormal placental attachment 1
- Attempts at forced placental removal can result in profuse hemorrhage and should be avoided 1
Special Considerations
- For cases with suspected bladder involvement, consider ureteric stent placement and collaboration with urologic surgeons 1
- Prophylactic intraoperative uterine artery embolization may reduce blood loss in cases of major placenta previa, though evidence is limited 4
- Regional anesthesia for cesarean delivery in women with placenta previa is generally safe 3
Complications and Management
- Major complications include massive hemorrhage requiring blood transfusion 3, 4
- In cases of placenta accreta spectrum, cesarean hysterectomy may be necessary 1
- Close monitoring of volume status, urine output, blood loss, and hemodynamics is critical during surgery 1
Follow-up Care
- Monitor for postpartum hemorrhage in the immediate postpartum period 3
- Ensure adequate iron supplementation and follow-up of hemoglobin levels if significant blood loss occurred 1
By following this structured approach to the management of placenta previa, maternal and perinatal morbidity and mortality can be significantly reduced.